US 10793636
Anti-CD73 antibodies
granted A61KA61K2039/505A61P
Quick answer
US patent 10793636 (Anti-CD73 antibodies) held by Corvus Pharmaceuticals, Inc. expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Corvus Pharmaceuticals, Inc.
- Grant date
- Tue Oct 06 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 10
- CPC classes
- A61K, A61K2039/505, A61P, A61P35/00